Association between obesity history and hand grip strength in older adults - Exploring the roles of inflammation and insulin resistance as mediating factors

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 66 A, Issue 3, 2011, Pages 341-348

  Stenholm, Sari ^a   Sallinen, Janne ^b   Koster, Annemarie ^c,d   Rantanen, Taina ^e   Sainio, Päivi ^a   Heliövaara, Markku ^a   Koskinen, Seppo ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF JYVÄSKYLÄ   (Finland)

Author keywords

Aging; Inflammation; Insulin resistance; Muscle strength; Obesity

Indexed keywords

C REACTIVE PROTEIN;

AGED; ARTICLE; BODY HEIGHT; BODY MASS; FEMALE; FINLAND; HAND STRENGTH; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MALE; MIDDLE AGED; MUSCLE STRENGTH; OBESITY; PHYSIOLOGY; RISK FACTOR;

AGED; BODY HEIGHT; BODY MASS INDEX; C-REACTIVE PROTEIN; FEMALE; FINLAND; HAND STRENGTH; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MALE; MIDDLE AGED; MUSCLE STRENGTH; OBESITY; RISK FACTORS;

EID: 79955098011     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glq226     Document Type: Article

References (41)

1. Rantanen T, Harris T, Leveille SG, et al. Muscle strength and body mass index as long-term predictors of mortality in initially healthy men. J Gerontol A Biol Sci Med Sci. 2000;55A:M168-M173. (Pubitemid 30243739)
2. Ferrucci L, Penninx BWJH, Volpato S, et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc. 2002; 50:1947-1954. (Pubitemid 35462439)
3. Roubenoff R. Sarcopenic obesity: the confluence of two epidemics. Obes Res. 2004;12:887-888. (Pubitemid 41202387)
4. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005;115:911-919. quiz 920.
5. Hung J, McQuillan BM, Thompson PL, Beilby JP. Circulating adipo-nectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. Int J Obes (Land). 2008;32:772-779. (Pubitemid 351670618)
6. Visser M, Pahor M, Taaffe DR, et al. Relationship of interleukin-6 and tumor necrosis factor-α with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci. 2002;57A:M326-M332. (Pubitemid 34464974)
7. Schaap LA, Pluijm SM, Deeg DJ, et al. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci. 2009;64:1183-1189.
8. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444:840-846. (Pubitemid 46024990)
9. Abbatecola AM, Ferrucci L, Ceda G, et al. Insulin resistance and muscle strength in older persons. J Gerontol A Biol Sci Med Sci. 2005;60A: 1278-1282. (Pubitemid 41612420)
10. Barzilay JI, Cotsonis GA, Walston J, et al. Insulin resistance is associated with decreased quadriceps muscle strength in nondiabetic adults aged >or=70 years. Diabetes Care. 2009;32:736-738.
11. Park SW, Goodpaster BH, Strotmeyer ES, et al. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the Health, Aging, and Body Composition study. Diabetes Care. 2007;30: 1507-1512. (Pubitemid 46871162)
12. Aromaa A and Koskinen S eds. Health and Functional Capacity in Finland. Baseline Results of the Health 2000 Health Examination Survey; Helsinki, Finland: Publications of the National Public Health Institute B12/2004; 2004. http://www.terveys2000.fi/julkaisut/baseline.pdf. Accessed May 10, 2010.
13. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. Geneva, Switzerland: WHO Technical Report Series 894; 2000.
14. Lauretani F, Russo C, Bandinelli S, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95:1851-1860. (Pubitemid 37310367)
15. Rantanen T, Era P, Kauppinen M, Heikkinen E. Maximal isometric muscle strength and socioeconomic status, health, and physical activity in 75-year-old persons. J Aging Phys Act. 1994;2:206-220.
16. Sainio P, Koskinen S, Natunen S. Functional capacity. In: Heistaro S (ed). Methodology Report. Health 2000 Survey; Helsinki, Finland: Publications of the National Health Institute B26/2008; 2008:92-105. http://www.terveys2000.fi/ doc/methodologyrep.pdf. Accessed May 10, 2010.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419. (Pubitemid 15018832)
18. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57-63. (Pubitemid 30022895)
19. Yearbook of Alcohol and Drug Statistics. Helsinki, Finland: National Research and Development Centre for Welfare and Health (STAKES); 2003.
20. Wilhelmsen L, Tibblin G, Werko L. A primary preventive study of Gothenburg, Sweden. Prev Med. 1972;1:153-160.
21. Houston DK, Ding J, Nicklas BJ, et al. The association between weight history and physical performance in the Health, Aging and Body Composition study. Int J Obes (Lond). 2007;31:1680-1687. (Pubitemid 350027470)
22. Houston DK, Ding J, Nicklas BJ, et al. Overweight and obesity over the adult life course and incident mobility limitation in older adults: the Health, Aging and Body Composition Study. Am J Epidemiol. 2009;169:927-936.
23. Stenholm S, Rantanen T, Alanen E, Reunanen A, Sainio P, Koskinen S. Obesity history as a predictor of walking limitation at old age. Obesity. 2007;15:929-938. (Pubitemid 46740968)
24. Schrager MA, Metter EJ, Simonsick E, et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol. 2007; 102: 919-925. (Pubitemid 46377013)
25. Carlsson S, Persson PG, Alvarsson M, et al. Weight history, glucose intolerance, and insulin levels in middle-aged Swedish men. Am J Epidemiol. 1998;148:539-545. (Pubitemid 128471701)
26. Wannamethee SG, Shaper AG. Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care. 1999;22:1266-1272. (Pubitemid 29350235)
27. Sakurai Y, Teruya K, Shimada N, et al. Association between duration of obesity and risk of non-insulin-dependent diabetes mellitus. The Sotetsu Study. Am J Epidemiol. 1999;149:256-260. (Pubitemid 29053166)
28. Pontiroli AE, Galli L. Duration of obesity is a risk factor for non-insulin-dependent diabetes mellitus, not for arterial hypertension or for hyperlipidaemia. Acta Diabetol. 1998;35:130-136.
29. Everhart JE, Pettitt DJ, Bennett PH, Knowler WC. Duration of obesity increases the incidence of NIDDM. Diabetes. 1992;41:235-240.
30. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007;56:1010-1013. (Pubitemid 46525079)
31. Goodpaster BH, Krishnaswami S, Resnick H, et al. Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care. 2003;26:372-379. (Pubitemid 36929058)
32. Delmonico MJ, Harris TB, Visser M, et al. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr. 2009;90(6):1579-1585.
33. Janssen I, Katzmarzyk PT, Ross R. Duration of overweight and metabolic health risk in American men and women. Ann Epidemiol. 2004;14:585-591. (Pubitemid 39221238)
34. Manninen P, Riihimäki H, Heliövaara M, Suomalainen O. Weight changes and the risk of knee osteoarthritis requiring arthroplasty. Ann Rheum Dis. 2004;63:1434-1437. (Pubitemid 39433947)
35. Schafer MH, Ferraro KF. Obesity and hospitalization over the adult life course: does duration of exposure increase use? J Health Soc Behav. 2007;48:434-449.
36. Zamboni M, Mazzali G, Fantin F, Rossi A, Di Francesco V. Sarcope-nic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis. 2008;18:388-395.
37. Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, Ferrucci L. Sarcopenic obesity - definition, cause and consequences. Curr Opin Clin Nutr Metab Care. 2008;11:693-700.
38. Bouchard DR, Janssen I. Dynapenic-obesity and physical function in older adults. J Gerontol A Biol Sci Med Sci. 2010;65:71-77.
39. Stenholm S, Alley D, Bandinelli S, et al. The effect of obesity combined with low muscle strength on decline in mobility in older persons: results from the InCHIANTI Study. Int J Obes (Land). 2009;33:635-644.
40. Perry GS, Byers TE, Mokdad AH, Serdula MK, Williamson DF. The validity of self-reports of past body weights by U.S. adults. Epidemiology. 1995;6:61-66.
41. Tamakoshi K, Yatsuya H, Kondo T, et al. The accuracy of long-term recall of past body weight in Japanese adult men. Int J Obes Relat Metab Disord. 2003;27:247-252. (Pubitemid 36255808)